Is Minapharm Pharmaceuticals SAE halal to invest in?

According to Musaffa's Shariah screening methodology, Minapharm Pharmaceuticals SAE (MIPH.CA) is currently classified as NOT HALAL as of December 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Minapharm Pharmaceuticals SAE a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Minapharm Pharmaceuticals SAE using these criteria to determine its compliance status.

Can Muslims buy shares of Minapharm Pharmaceuticals SAE?

Muslim investors may consider investing in Minapharm Pharmaceuticals SAE if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Minapharm Pharmaceuticals SAE classified as NOT HALAL?

Musaffa determines the Shariah status of Minapharm Pharmaceuticals SAE by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Minapharm Pharmaceuticals SAE updated?

The Shariah compliance status of Minapharm Pharmaceuticals SAE may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Minapharm Pharmaceuticals SAE become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Minapharm Pharmaceuticals SAE?

You can check the latest Shariah compliance status of Minapharm Pharmaceuticals SAE on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

MIPH.CA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: December 27, 2025

Report Source: 2025 3rd Quarter Report

Minapharm Pharmaceuticals SAE. Stock Analysis MIPH.CA

Egypt Health Care Micro Cap Report: Q3, 2025

Minapharm Pharmaceuticals engages in the manufacture and marketing of pharmaceutical products. The company is headquartered in Cairo, Cairo. The company went IPO on 2004-01-11. The Company’s production falls into seven lines, namely Gastroenterology, Ophthalmology, Cardiology, Biogenetics, Dermatology, Dermatology, Orthopedic and Miscellaneous products such as betolvex, broncho-vaxom adult, broncho-vaxom infantile, burinex, chlorhexidine tulle, chlorhexidine tulle, ciloprine, daktacort cream, daktarin cream, desatura, dicynone, among others. Minapharm is in cooperation with several international pharmaceutical companies and it distributes its products within and outside Egypt.

Key Statistics of Minapharm Pharmaceuticals SAE (MIPH.CA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

EGP686.20EGP717.99

Today's Open

EGP698.00

Volume

4211.00

P/E Ratio (TTM)

50.11

52 Week Range

EGP175.00EGP772.00

Market Cap

8.13B

Avg. Volume

9430.10

Dividend Yield

0.66%

Financial Metrics & Statements of Minapharm Pharmaceuticals SAE (MIPH.CA)

FAQ's for Minapharm Pharmaceuticals SAE (MIPH.CA)

According to Musaffa’s Shariah screening methodology, Minapharm Pharmaceuticals SAE (MIPH.CA) is currently classified as NOT HALAL as of December 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.